Innovations in IBD Management: Expanding Possibilities with Treat-to-Target Strategies July 29, 2021

Claiming Credit 

Thank you for attending Innovations in IBD Management: Expanding Possibilities with Treat-to-Target Strategies on July 29, 2021. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to claim your credit on the following page.

 

Inflammatory bowel disease (IBD) as a whole saddles subsets of patients with a lifetime of treatment, and with that, a lifetime of potential complications. The prevention of disease progression, as well as finding the correct equilibrium between aggressive treatment and the risk of adverse events is required for the maximization of individual patient outcomes. The future of IBD treatment holds many possibilities with the number of new options currently being studied. This virtual grand rounds series will help gastroenterology clinicians better elucidate the place in therapy for some of the newer agents on the horizon and be familiar with their mechanisms, safety, and efficacy data.

Target Audience

Key members of the IBD patient care team including: gastroenterologists, gastroenterology fellows, surgeons, NP/PAs, nurses, and other relevant clinicians who collaboratively treat/manage patients with IBD. 

Learning Objectives

At the conclusion of this activity, participants will be able to:

  1. Assess targets of mucosal healing used in treat-to-target strategies and the evidence that exists to support the use of these strategies in IBD patients.
  2. Examine novel agents for IBD in terms of therapeutic target, safety and efficacy data, and place in therapy.
  3. Evaluate key considerations and the latest emerging data for managing IBD in the era of COVID-19.
  4. Design personalized treatment plans for patients with IBD that will improve patient outcomes and decrease heterogeneity that exists in the treatment of IBD.
  5. Utilizing case-based vignettes with actual patients, establish strategies to openly discuss IBD symptoms and patient desires to drive a more patient-oriented treatment approach.

 

This activity is supported by unrestricted educational grant from AbbVie, Gilead, and Takeda.

Course summary
Available credit: 
  • 1.00 ABCGN
    According to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN. Specific Category Approved: Hours Approved: 1.00
  • 1.00 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • 1.00 Participation
Course opens: 
07/29/2021
Course expires: 
07/29/2022
Rating: 
0
FACULTY

Alan Moss, MD, FACG, FEBG, AGAF, FRCPI
Director, Crohn’s & Colitis Program,
Gastroenterology
Boston Medical Center
Professor of Medicine
Boston University School of Medicine

Dr. Moss is a consultant for Janssen, Pfizer and receives grant support from Pfizer.

Christina Ha, MD, FACG, AGAF
Associate Professor of Medicine
The F Widjaja Foundation Inflammatory Bowel Immunology Research Institute at Cedars-Sinai
Los Angeles, CA

Dr. Ha is on the advisory board for AbbVie, Genetech, Janssen, InDex Pharmaceuticals, Lilly, Salix, and Takeda. Dr. Ha is a consultant and speaker for AbbVie. She also receives research support from Lilly and Pfizer.

CME Project Manager: Michael Burk

 

ACCME
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

NCPD
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Contact Hours: 1.0 of which 1.0 is eligible for pharmacology credit.

ABCGN
According to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN.

Available Credit

  • 1.00 ABCGN
    According to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN. Specific Category Approved: Hours Approved: 1.00
  • 1.00 AMA PRA Category 1 Credit™
    Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Boston University School of Medicine designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 ANCC
    Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
  • 1.00 Participation
Please login or register to take this course.


Please click on "Take Course" above to begin the credit claiming process. 

 

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS.  ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE.  TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS.  IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS.  IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.